Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Trends, survival and regional control of sentinel lymph node biopsy versus axillary dissection in cN0 breast cancer: a multicenter cohort in China.

Frontiers in oncology·2026

Same author

OTUB1 Promotes HCC Progression by Regulating Glycolysis Through Deubiquitination of PKM2.

Molecular carcinogenesis·2026

Same author

Oncogenic driver and therapeutic target: Prolactin signalling axis in retroperitoneal sarcoma.

Clinical and translational medicine·2026

Same author

Ginsenoside Rg1 Attenuates Renal Ischemia-Reperfusion Injury and Fibrosis by Suppressing Pro-Inflammatory Macrophage Activation.

Journal of inflammation research·2026

Same author

Author Correction: The Artemisia argyi oil reduces high-fat diet-induced obesity by enhancing thermogenesis in brown adipose tissue.

NPJ science of food·2026

Same author

IR-780 improves urination function and complications in rats with partial bladder outlet obstruction by protecting bladder smooth muscle cell mitochondria from oxidative stress.

Frontiers in pharmacology·2026

Search research articles

Related Experiment Video

Updated: Jun 30, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Exosomal IGFBP2 derived from highly metastatic promotes hepatocellular carcinoma metastasis by inducing epithelial

Yongyuan Zheng¹, Weibing Li¹, Yansong Huang¹

¹Department of Hepatology and Infectious Diseases, the Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, PR China.

|March 15, 2024

Summary

This summary is machine-generated.

Exosomes from high metastatic liver cancer cells promote metastasis in less aggressive cells by delivering IGFBP2, which activates the ERK pathway. Targeting exosomal IGFBP2 offers a potential treatment strategy for liver cancer patients.

Keywords:

EMT Exosomes IGFBP2 Liver cancer Metastasis

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 30, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Area of Science:

Oncology
Cell Biology
Biochemistry

Background:

Liver cancer metastasis is a primary cause of mortality.
Exosomes mediate intercellular communication and are implicated in cancer progression.
Understanding exosome-driven metastasis is crucial for developing effective liver cancer therapies.

Purpose of the Study:

To investigate the role of exosomes from highly metastatic liver cancer cells in promoting liver cancer metastasis.
To identify specific molecules within these exosomes responsible for enhancing metastatic potential.
To elucidate the molecular mechanisms by which these exosomes influence cancer cell behavior.

Main Methods:

Bioinformatics analysis of exosomal mRNAs from patient plasma.
Exosome characterization using Transmission Electron Microscopy (TEM), Nanoparticle Tracking Analysis (NTA), and protein blotting.
Functional assays including CCK8, Transwell, Tunel, RTqPCR, Western blot, and immunofluorescence staining.
Analysis of Insulin-like Growth Factor Binding Protein 2 (IGFBP2) expression and its impact on the ERK signaling pathway and epithelial-mesenchymal transition (EMT).

Main Results:

Exosomes derived from highly metastatic liver cancer cells (MHCC97H) contain elevated levels of IGFBP2.
IGFBP2 in these exosomes enhances the metastatic potential of less aggressive liver cancer cells (Hep3B).
Exosomal IGFBP2 activates the ERK signaling pathway in recipient cells, inducing EMT.
Elevated IGFBP2 in plasma exosomes correlates with poor prognosis in liver cancer patients.

Conclusions:

Exosomal IGFBP2 from highly metastatic liver cancer cells acts as a key mediator of cell-to-cell communication driving liver cancer metastasis.
IGFBP2 facilitates metastasis by activating the ERK signaling pathway and promoting EMT.
Targeting exosomal IGFBP2 presents a promising therapeutic strategy for improving treatment outcomes and prognosis in liver cancer.